Potassium Carbonate → HCID 46244317, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]2[NH:12][C:11](=[O:13])[N:10]([CH:14]3[CH2:19][CH2:18][NH:17][CH2:16][CH2:15]3)[CH2:9][CH2:8][C:7]=2[CH:20]=1.Cl[C:22]1[N:27]=[CH:26][N:25]=[C:24]([N:28]([C:32]2[CH:42]=[C:41]([CH3:43])[C:35]3[N:36]([CH3:40])[C:37](=[O:39])[O:38][C:34]=3[CH:33]=2)[C:29](=[O:31])[CH3:30])[CH:23]=1.C(=O)([O-])[O-].[K+].[K+]>CN1C(=O)CCC1>[CH3:40][N:36]1[C:35]2[C:41]([CH3:43])=[CH:42][C:32]([N:28]([C:24]3[CH:23]=[C:22]([N:17]4[CH2:18][CH2:19][CH:14]([N:10]5[CH2:9][CH2:8][C:7]6[CH:20]=[C:3]([O:2][CH3:1])[CH:4]=[CH:5][C:6]=6[NH:12][C:11]5=[O:13])[CH2:15][CH2:16]4)[N:27]=[CH:26][N:25]=3)[C:29](=[O:31])[CH3:30])=[CH:33][C:34]=2[O:38][C:37]1=[O:39]Participants
5
Conditions
- Temperature
- 80 °C
Procedure
59 mg (0.21 mmol) 7-methoxy-3-piperidin-4-yl-1,3,4,5-tetrahydro-1,3-benzodiazepin-2-one, 65 mg (0.19 mmol) N-(6-chloro-pyrimidin-4-yl)-N-(3,4-dimethyl-2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide and 81 mg (0.59 mmol) potassium carbonate in 1.5 mL NMP were combined and stirred at 80° C. The reaction mixture was purified by preparative HPLC. The product-containing fractions were combined and evaporated down. The solid obtained was washed with diethyl ether and dried.
Workup
- customThe reaction mixture was purified by preparative HPLC
- customevaporated down
- customThe solid obtained
- washwas washed with diethyl ether
- customdried
Sources & evidence
- ORD record
- ord-d96357fa18f04c459a45823163da28f5
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08952014B2
Reaction notes
Loading…